4SC AG Valeur d'entreprise
Quel est le Valeur d'entreprise de 4SC AG?
Le Valeur d'entreprise de 4SC AG est -$12.03
Quelle est la définition de Valeur d'entreprise?
La valeur d'entreprise est une mesure de la valeur marchande totale d'une entreprise. Il correspond à la capitalisation boursière avec la dette, les intérêts minoritaires et les actions privilégiées moins la trésorerie et les équivalents de trésorerie totaux.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valeur d'entreprise des entreprises dans Health Care secteur sur XETRA par rapport à 4SC AG
Que fait 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Entreprises avec valeur d'entreprise similaire à 4SC AG
- Hydraulique P.B Societe anonyme a Valeur d'entreprise de -$12.42
- Brand Architekts plc a Valeur d'entreprise de -$12.30
- Ocean Line Port Development a Valeur d'entreprise de -$12.28
- Neptune Wellness Solutions a Valeur d'entreprise de -$12.24
- Wisdom Sports a Valeur d'entreprise de -$12.18
- Orphazyme A/S a Valeur d'entreprise de -$12.12
- 4SC AG a Valeur d'entreprise de -$12.03
- Trilogy International Partners a Valeur d'entreprise de -$12.02
- Watchstone Plc a Valeur d'entreprise de -$11.75
- 360 Ludashi a Valeur d'entreprise de -$11.41
- KOALA a Valeur d'entreprise de -$11.26
- Sing Tao News a Valeur d'entreprise de -$11.07
- Amuse a Valeur d'entreprise de -$10.86